Question explored with the scientific record
\what is known about CBD (broad spectrum or isolate) and CBN for sleep
The short version: CBD for sleep is mostly promise, not proven benefit, and CBN is barely studied at all.
The best sleep trial here does not even use CBD alone. It gave healthy cannabis novices low-dose THC:CBD, including a CBD-heavy 5 mg THC / 80 mg CBD mix, and found no significant change in sleep onset, total sleep time, or awakenings versus placebo [2]. Small doses of the combination did not move sleep. A 60 mg/day CBD hemp extract trial in overweight adults found only marginal improvements in self-rated sleep quality and quantity, with no hard clinical sleep measures [3].
What does appear to help is THC-dominant cannabis. In PTSD patients using THC-predominant flower, sleep scores (PSQI) improved significantly at 3 and 6 months, but this was an unblinded observational registry with no control group and no placebo [4]. Selection bias is baked in: people who kept using and felt better reported back.
Broad-spectrum and isolate are not distinguished in any trial here. CBN has no sleep trial in this evidence at all. The retrospective canine study of THC-free broad-spectrum hemp oil [1] says nothing about human sleep.
My call: there is no solid randomized evidence that CBD, broad-spectrum or isolate, produces meaningful sleep improvement, and none for CBN. The THC signal [4] is real but confounded. Confidence: moderate on CBD, low on CBN.
Sources used 4
-
Uso de cannabidiol (CBD) y tetrahidrocannabinol (THC) en el manejo de la dermatitis atópica en perros
This narrative review found possible antipruritic effects of CBD in canine atopic dermatitis without consistent skin lesion or inflammatory marker improvement, while THC efficacy remains unestablished and safety is dose-related.
DOI: 10.23857/pc.v11i10.12604 -
Same-Day Sedative and Night-Time Sleep Effects Following Combined Cannabinoid Formulations: A Randomised-Controlled Trial
In a five-week, double-blind, placebo-controlled cross-over trial in healthy adult novices to cannabis, the study tested daytime sedation and indirect night-time sleep effects of four low-dose THC:CBD formulations (1:1 and 1:16) versus placebo, finding no significant daytime sle…
DOI: 10.1007/s40261-025-01455-6 -
Effects of Hemp Extract on Markers of Wellness, Stress Resilience, Recovery and Clinical Biomarkers of Safety in Overweight, But Otherwise Healthy Subjects
A randomized, double-blind, placebo-controlled trial in overweight but otherwise healthy adults assessing the effects of a CBD-containing hemp oil extract on wellness markers, stress resilience, recovery, body composition, and safety biomarkers, finding a significant improvement…
DOI: 10.1080/19390211.2020.1765941 -
Controlled Inhalation of Tetrahydrocannabinol-Predominant Cannabis Flos Mitigates Severity of Post-Traumatic Stress Disorder Symptoms and Improves Quality of Sleep and General Mood in Cannabis-Experienced UK Civilians: A Real-World, Observational Study
THC-predominant cannabis flower inhalation in cannabis-experienced UK civilians with PTSD, studied via the Project Twenty21 real-world registry, is associated with significant reductions in overall PTSD symptom severity across clusters, along with improved sleep and mood over 3–…
DOI: 10.1159/000540978